Rob Peets International Wex Technologies WXI-T WAIT Oct 22, 2002

In phase 2 clinical trials in Canada andChina. Trading in a $2/2.50 range. In current negotiations.

Rob Peets

Unknown

Unlock Rating

$2.000

Stock price when the opinion was issued

misc industrial products

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

WATCH

WEX Pharmaceutical recently failed its trials. The company now has to regroup and decide what to do next. It is a long process to rebuild. The vice-president stepped down as well recently. Recommends looking at how much cash the company has before entering.

Most Recent Experts

Stockchase Insights

5i Research

Michael Hakes - CFA, MBA

Murray Wealth Group

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Jim Lebenthal

Cerity Partners

Brenda Vingiello, CIO, Sand Hill Global Advisors

Sand Hill Global Advisors

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Rob Peets International Wex Technologies WXI-T WAIT Oct 22, 2002

You might be interested:

International Wex Technologies(WXI-T)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals